segments: FMC Agricultural Solutions and FMC Lithium. Our FMC Agricultural Solutions segment develops, markets and sells all three major classes of crop protection chemicals: insecticides, herbicides and fungicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as in non-agricultural markets for pest control. Our FMC Lithium segment manufactures lithium for use in a wide range of lithium products, which are used primarily in energy storage, specialty polymers and chemical synthesis application.
In March 2017, we announced our intention to separate our FMC Lithium segment, subsequently renamed Livent corporation, or Livent, into a publicly traded company. The initial step of the separation, the initial public offering of Livent, closed on October 15, 2018. We presently intend to distribute the remaining Livent shares to our stockholders on March 1, 2019. At that time, results of FMC Lithium will be presented as a discontinued operation.
We were incorporated in 1928 under Delaware law and have our principal executive offices at 2929 Walnut Street, Philadelphia, Pennsylvania 19104. Our telephone number is(215) 299-6000.
USE OF PROCEEDS
Unless we inform you otherwise in a prospectus supplement or free writing prospectus, the net proceeds from the sale of the securities will be used for general corporate purposes, including working capital, acquisitions, repurchases of common stock, capital expenditures and the repayment of indebtedness.
DESCRIPTION OF SECURITIES WE MAY OFFER
This prospectus contains summary descriptions of the common stock, preferred stock, debt securities, warrants, depositary shares, stock purchase contracts and stock purchase units that we may offer and sell from time to time. These summary descriptions are not meant to be complete descriptions of each security. However, at the time of an offering and sale, this prospectus together with the accompanying prospectus supplement will contain the material terms of the securities being offered, including the specific types, amounts, prices and detailed terms of any of these securities.
DESCRIPTION OF CAPITAL STOCK
The following description of our common stock and preferred stock will apply generally to any future common stock or preferred stock that we may offer, but is not complete. We will describe the particular terms of any class or series of these securities in more detail in the applicable prospectus supplement. For more information regarding the common stock and preferred stock that may be offered by this prospectus, please refer to our restated certificate of incorporation and our restatedby-laws, as amended, which are incorporated by reference as exhibits to the registration statement of which this prospectus is a part.
The summary below and that contained in any prospectus supplement are not complete and are qualified in their entirety by reference to our restated certificate of incorporation and restatedby-laws, as amended. The terms of these securities also may be affected by the General Corporation Law of the State of Delaware, or the DGCL.
Description of Common Stock
Our authorized common stock consists of 260 million shares of common stock, $0.10 par value. As of December 31, 2018, there were 132,281,614 shares of common stock issued and outstanding. In addition, up to 4.4 million shares of unissued common stock have been reserved for stock options and awards under our
-3-